versión imprimible

3rd mRNA-Based Therapeutics Summit

Evvnt Promotion / evvnt
26.07.2023 - 28.07.2023  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 9:00 am to 6:00 pm
Temas de la conferencia
The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shakers in the mRNA industry. 500+ industry pioneers from the likes of the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more are joining the world's only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
La Sociedad Científica
Hanson Wade
Speakers: Michiel Lodder, CEO, 20Med Therapeutics, Walter Schmidt, Director – mRNA Division, ADvantage Therapeutics, Renhuan Xu, CEO and Co-Founder, ARV Technologies, Petro Terblanche, Managing Director, Afrigen Biologics and More.

Información e inscripción:
Ms. Rosie Andre
Salud Pública, Servicios de salud
Cuota del Congreso
USD 2699.00 - USD 6146.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

European Health Forum GasteinHilfswerk AustriaÖsterreichische Akademie der ÄrzteEuropean Public Health Association (EUPHA)newTreeÖsterreichische Gesellschaft für Public HealthÖsterreichisches Rotes KreuzAlumni Club Medizinische Universität Wien